HeartSciences Inc.
HSCS- Exchange
- Nasdaq
- Industry
- Finance Services
- SEC CIK
- 0001468492
No open-market purchases or sales by HeartSciences Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $385.8K in total; no superinvestor holds it.
Other share classesHSCSW
13F holders, Q2 2024
Institutional positions in HeartSciences Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 7
- −16 vs. Q1 2024
- Shares held
- 10.3K
- −1.54M (−99.3%) vs. Q1 2024
- Total value
- $53.4K
- −$127.7K (−70.5%) vs. Q1 2024
- New holders
- 3
- 0 more added
- Sold out
- 19
- 4 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HSCS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $385.8K |
| Q1 2026 | 13 | $538.7K |
| Q4 2025 | 10 | $610.2K |
| Q3 2025 | 12 | $611.6K |
| Q2 2025 | 7 | $219.8K |
| Q1 2025 | 5 | $66.3K |
| Q4 2024 | 3 | $5.40K |
| Q3 2024 | 6 | $61.9K |
| Q2 2024 | 7 | $53.4K |
| Q1 2024 | 23 | $181.1K |
| Q4 2023 | 19 | $203.4K |
| Q3 2023 | 10 | $232.3K |
| Q2 2023 | 11 | $545.1K |
| Q1 2023 | 11 | $578.8K |
| Q4 2022 | 8 | $372.3K |
| Q3 2022 | 6 | $80.0K |
| Q2 2022 | 4 | $83.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding HeartSciences Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 6,396 | $33.3K | 0.00% | +6,396 | New |
| Morgan Stanley | 2,290 | $11.9K | 0.00% | +2,290 | New |
| Tower Research Capital LLC (TRC) | 576 | $3.00K | 0.00% | −61,913−99.1% | Reduced |
| Cultivar Capital, Inc. | 500 | $2.60K | 0.00% | −49,500−99.0% | Reduced |
| Oliver Lagore Vanvalin Investment Group | 485 | $2.53K | 0.00% | −69,873−99.3% | Reduced |
| Bank of America Corp | 4 | $21 | 0.00% | +4 | New |
| JPMorgan Chase & Co | 1 | $5 | 0.00% | −9−90.0% | Reduced |
| Vanguard Group Inc | 0 | $0 | 0.00% | −191,541−100.0% | Sold out |
| Tradition Wealth Management, LLC | 0 | $0 | 0.00% | −180,465−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −165,373−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −123,086−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −122,465−100.0% | Sold out |
| HCR Wealth Advisors | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Astoria Strategic Wealth, Inc. | 0 | $0 | 0.00% | −81,995−100.0% | Sold out |
| First Western Trust Bank | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −50,538−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −49,180−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −45,822−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −42,316−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −24,307−100.0% | Sold out |
| AlphaStar Capital Management, LLC | 0 | $0 | 0.00% | −19,993−100.0% | Sold out |
| Accurate Wealth Management, LLC | 0 | $0 | 0.00% | −20,400−100.0% | Sold out |
| Chapin Davis, Inc. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −14,122−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −453−100.0% | Sold out |